Analysis device, MRI system, analysis method, and analysis program

The MRI-based analysis device addresses limitations of current breast cancer screening by accurately distinguishing between benign and malignant calcifications through phase unwrapping and slope analysis, enhancing detection and reducing patient discomfort.

WO2026235166A1PCT designated stage Publication Date: 2026-11-12UNIV OKAYAMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2026/017476
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-07
Filing Date
2026-05-07
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Current breast cancer screening methods such as palpation, visual examination, ultrasonography, and mammography face challenges in detecting small lesions and microcalcifications, leading to low implementation rates and limited detection capabilities.

Method used

An analysis device and method that utilizes an MRI system to analyze MR signals by performing phase unwrapping, high-frequency component enhancement, and slope derivation to differentiate between benign and malignant calcifications, and identify calcium phosphate or oxalate, using an MRI system with an analysis device comprising a reference storage unit, phase acquisition, correction, slope derivation, and support information derivation.

Benefits of technology

Enables accurate determination of breast cancer characteristics without causing discomfort, potentially increasing screening rates and enabling early detection and treatment, applicable to various body parts including the chest and lower abdomen, and other conditions expressing calcium salts.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2026017476_12112026_PF_FP_ABST
    Figure JP2026017476_12112026_PF_FP_ABST
Patent Text Reader

Abstract

Provided are an analysis device, etc., with which it is possible to assist a physician in determining the state of a subject. An analysis device 2 analyzes an MR signal obtained from a subject by an MRI device. The analysis device 2: acquires a phase component from the MR signal (step S3); corrects the acquired phase component through an unwrapping process (step S4); derives, from the corrected phase component, the slope of the phase value with respect to echo time (step S6); compares the derived slope with a reference set in advance (step S7); derives, on the basis of the result of the comparison, assistance information for assisting in the determination of the state of the subject (step S8); and outputs the derived assistance information (step S9).
Need to check novelty before this filing date? Find Prior Art

Description

Analysis device, MRI system, analysis method, and analysis program

[0001] The present application relates to an analysis device that analyzes MR (Magnetic Resonance) signals obtained from a subject by an MRI (Magnetic Resonance Imaging) apparatus, an MRI system equipped with such an analysis device, an analysis method executed by such an MRI system, and an analysis program for realizing such an analysis device.

[0002] According to cancer statistics from the National Cancer Center, breast cancer is the most common cancer in women in terms of incidence (2019), and ranks fifth in terms of mortality (2020). On the other hand, it is stated that over 90% cure rate can be expected for breast cancer if early detection and early treatment are performed.

[0003] As breast cancer screening methods, methods such as palpation and visual examination, ultrasonography, and mammography are widely used. Palpation and visual examination have the problem that small lesions (lumps) are difficult to detect. Ultrasonography facilitates detection of small lesions, but has the problem that it is difficult to image calcifications. Mammography can detect fine calcifications, but has the problem that it is painful as it is necessary to compress, spread and thin the mammary glands during the examination. Due to such problems, the actual breast cancer screening implementation rate is by no means high. Accordingly, for example, Patent Document 1 proposes attempting to detect microcalcifications in the breast region from an MRI (Magnetic Resonance Imaging) phase image of breast tissue.

[0004] Japanese Unexamined Patent Publication (National Publication of Translated Version) No. 2023-518487

[0005] However, palpation and visual examination, ultrasonography, and mammography each have the aforementioned problems. In addition, the method using an MRI phase image as proposed in Patent Document 1 is limited to the detection of microcalcifications.

[0006] The present invention has been made in view of such circumstances, and the main purpose of the present application is to disclose an analysis device that supports determination of the state of a subject based on MR signals obtained from the subject by an MRI apparatus.

[0007] Furthermore, this application also aims to provide an MRI system equipped with the analysis device disclosed herein.

[0008] Furthermore, another objective of this application is to disclose an analysis method performed using the analysis apparatus disclosed herein.

[0009] Furthermore, this application aims to disclose an analysis program for realizing the analysis device disclosed herein.

[0010] To solve the above problems, the analysis device disclosed in this application is an analysis device for analyzing an MR (Magnetic Resonance) signal obtained from a subject by an MRI (Magnetic Resonance Imaging) device, and is characterized by comprising: a reference storage unit that stores one or more references for comparison; a reference setting means that reads one reference from the reference storage unit and sets it for comparison; a phase acquisition means that acquires the phase component of the MR signal; a correction means that corrects the acquired phase component by unwrapping processing; a slope derivation means that derives the slope of the phase value with respect to the echo time from the corrected phase component; a comparison means that compares the derived slope with the set reference; and a support information derivation means that derives support information to assist in determining the state of the subject based on the comparison result.

[0011] Furthermore, the analysis apparatus is characterized in that the correction means performs high-frequency component enhancement processing on the unwrapping phase component.

[0012] Furthermore, in the analysis device, the subject is a human body, and the support information derivation means is characterized by deriving support information that assists in determining whether the observed object within the subject is benign or malignant, as a determination of the state of the subject based on the results of comparing the inclinations.

[0013] Furthermore, in the analysis device, the subject is a human body, and the support information derivation means derives support information that assists in determining whether the object of observation within the subject is calcium phosphate or calcium oxalate, as a determination of the state of the subject based on the results of comparing the inclinations.

[0014] Furthermore, in the analysis device, the subject is a human body, and the support information derivation means derives support information that assists in determining whether the object of observation within the subject is hydroxyapatite or wittrockite, based on the results of comparing the inclinations of the subject.

[0015] Furthermore, the MRI system disclosed herein is characterized by comprising an MRI device that applies a magnetic field and irradiates electromagnetic waves to a subject and acquires an MR signal, and an analysis device that analyzes the MR signal received by the MRI device.

[0016] Furthermore, the analysis method disclosed herein is an analysis method using an MRI (Magnetic Resonance Imaging) device and an analysis device for analyzing MR (Magnetic Resonance) signals obtained from a subject by the MRI device, characterized in that it performs a reference setting step of reading one reference from a reference storage unit that stores one or more references for comparison and setting it for comparison; a phase acquisition step of acquiring the phase component of the MR signal; a correction step of correcting the acquired phase component by unwrapping; a slope derivation step of deriving the slope of the phase value with respect to the echo time from the corrected phase component; a comparison step of comparing the derived slope with the set reference; and a support information derivation step of deriving support information to assist in determining the state of the subject based on the comparison result.

[0017] Furthermore, the analysis program disclosed herein is an analysis program that causes a computer to analyze an MR (Magnetic Resonance) signal obtained from a subject by an MRI (Magnetic Resonance Imaging) device, and is characterized in that it causes the computer to execute a reference setting step of reading one reference from a reference storage unit that stores one or more references for comparison and setting it for comparison; a phase acquisition step of acquiring the phase component of the MR signal; a correction step of correcting the acquired phase component by unwrapping processing; a slope derivation step of deriving the slope of the phase value with respect to the echo time from the corrected phase component; a comparison step of comparing the derived slope with the set reference; and a support information derivation step of deriving support information to assist in determining the state of the subject based on the comparison result.

[0018] The analytical device disclosed in this application has excellent effects, such as being able to support the determination of the subject's condition by deriving the slope of the phase value with respect to the echo time.

[0019] This is a block diagram schematically showing an example of the MRI system disclosed in this application. This is an explanatory diagram conceptually showing an example of the contents of the reference memory unit of the analysis device provided in the analysis device provided in this application. This is a flowchart showing an example of the analysis processing of the analysis device provided in the MRI system disclosed in this application. This is an explanatory diagram conceptually showing the motion of the MR signal processed by the analysis device disclosed in this application. This is an explanatory diagram conceptually showing the precession of the MR signal processed by the analysis device disclosed in this application. This is a graph showing the change in the phase component of the MR signal processed by the analysis device disclosed in this application. This is an explanatory diagram conceptually showing the unwrapping process of the MR signal processed by the analysis device disclosed in this application. This is a list of examples of images related to the MR signal processed by the analysis device disclosed in this application. This is a graph showing an example of the change in phase value with respect to echo time of the MR signal processed by the analysis device of this application. This is a graph showing an example of the results of experimental analysis processing by the analysis device of this application. This is a graph showing an example of the change in phase value with respect to echo time of the MR signal processed by the analysis device of this application.

[0020] Embodiments of the present invention will be described below with reference to the drawings.

[0021] <Application Examples> The analysis method disclosed in this application is implemented as an MRI system using various devices such as an MRI (Magnetic Resonance Imaging) device and an analysis device. The MRI system disclosed in this application contributes to assisting in the assessment of a subject's condition during medical examinations, particularly of the chest, lower abdomen, and other parts of the human body. Specifically, when calcification is observed in the chest of a subject, the MRI system disclosed in this application assists the physician's judgment by providing information to determine whether the observed object is benign calcium oxalate or malignant calcium phosphate. The MRI system SYS disclosed in this application, as shown in the drawings, will be described below with reference to the drawings.

[0022] <System Configuration> Figure 1 is a schematic block diagram showing an example of the MRI system SYS disclosed in this application. The MRI system SYS disclosed in this application is equipped with various devices such as an MRI device 1 and an analysis device 2. The MRI device 1 is a device that obtains an MR signal about the subject using magnetic resonance technology and outputs it to the analysis device 2. The analysis device 2 is a device that performs analysis processing based on the MR signal and outputs support information to assist the physician's decision as a result.

[0023] The MRI apparatus 1 includes various mechanisms such as an MR main unit mechanism 10 that obtains an MR signal showing an MRI image of a subject using magnetic resonance technology, and an MR control mechanism 11 that controls the MR main unit mechanism 10. The MR main unit mechanism 10 includes various devices such as a magnetic field generating unit 100, an electromagnetic wave irradiation unit 101, and a signal detection unit 102. The MR control mechanism 11 includes various devices such as a control unit 110, a drive unit 111, an output control unit 112, a signal input unit 113, a signal output unit 114, and an operation unit 115.

[0024] The magnetic field generating unit 100 of the MR main mechanism 10 is a device that generates a magnetic field around the subject using a magnet such as a permanent magnet or a superconducting magnet. The electromagnetic wave irradiation unit 101 is a device that irradiates the subject with electromagnetic waves such as RF pulses. The signal detection unit 102 is a device that detects the MR signal emitted from the subject using an RF receiving coil. The MR main mechanism 10 configured as described above generates a magnetic field around the subject using the magnetic field generating unit 100 to rotate hydrogen atoms, and irradiates the hydrogen atoms with electromagnetic waves using the electromagnetic wave irradiation unit 101 to resonate the hydrogen atoms. The signal detection unit 102 then detects the MR signal emitted by the hydrogen atoms and outputs it to the MR control mechanism 11.

[0025] The control unit 110 of the MR control mechanism 11 is a device that controls the entire MR control mechanism 11. The drive unit 111 is a device that drives the magnetic field generation unit 100, the electromagnetic wave irradiation unit 101, and the signal detection unit 102 of the MR main mechanism 10 under the control of the control unit 110. The output control unit 112 is a device that controls the output of the magnetic field generated by the magnetic field generation unit 100 and the electromagnetic waves irradiated by the electromagnetic wave irradiation unit 101 under the control of the control unit 110.

[0026] The signal input unit 113 is a device that receives the MR signal output from the MR main unit mechanism 10. The signal output unit 114 is a device that outputs the MR signal to the analysis device 2.

[0027] The operating section 115 of the MR control mechanism 11 is a device for the operator to input various commands when operating the MRI device 1, and is arranged in various forms such as an operating touch panel, various switches, various buttons, and various levers.

[0028] The MR control mechanism 11, configured as described above, performs various controls on the MR main unit mechanism 10 under the control of the control unit 110, and outputs the MR signal input from the MR main unit mechanism 10 to the analysis device 2.

[0029] The analysis device 2 is implemented using various computers, such as an operating computer, which is operated by an analysis specialist or other personnel. The analysis device 2 is equipped with various devices such as a control unit 20, a storage unit 21, an input unit 22, an operation unit 23, and an output unit 24. Although this description describes an implementation of the analysis device 2 using a single computer, it is also possible to implement it using multiple computers, such as a server computer and terminal devices that can access the server computer.

[0030] The control unit 20 is a processor such as a CPU (Central Processing Unit) that includes various circuits such as information processing circuits, timing circuits, and register circuits, and executes processes to control the entire device.

[0031] The storage unit 21 is a storage device composed of non-volatile memory such as hard disks, SSDs (Solid State Drives), RAID (Redundant Arrays of Inexpensive Disks), and flash memory, and volatile memory such as various types of RAM (Random Access Memory). The storage unit 21 stores various programs and data, such as a basic program (OS: Operating System) and application programs that run on the basic program. As application programs, for example, various programs such as the analysis program 210 for realizing the analysis apparatus 2 disclosed in this application are stored. As various data, for example, data indicating one or more comparison criteria such as various reference values ​​and reference ranges are stored in the reference storage unit 211, which is a storage area within the storage unit 21. The one or more comparison data stored are set as appropriate as comparison criteria.

[0032] Figure 2 is a conceptual diagram illustrating an example of the contents of the reference memory unit 211 of the analysis device 2 disclosed in this application. Figure 2 shows the contents of the reference memory unit 211 in table format. The reference memory unit 211 stores data that is set as standards, such as various reference values ​​and reference ranges, corresponding to disease / examination items. The standards, such as various reference values ​​and reference ranges, can be automatically or manually modified as appropriate, such as by adding, deleting, or correcting data, based on advancements in medical technology such as academic conference presentations, research presentations, law enactment, and law amendments, as well as the characteristics of hardware such as the MRI device 1.

[0033] Returning to the block diagram in Figure 1, the input unit 22 is a device that receives image signals output from the MRI apparatus 1. The operation unit 23 is a device used by the operator for operation input, such as a keyboard or mouse. The output unit 24 is an output device, such as a liquid crystal display (display means) or a printer (printing means).

[0034] The computer equipped with the various devices described above operates as an analysis device 2 by reading various programs, such as the analysis program 210, stored in the memory unit 21 under the control of the control unit 20, and executing various steps contained in the read programs. The analysis device 2 then performs analysis processing based on the MR signal input from the MRI device 1 and outputs support information resulting from the analysis processing.

[0035] <Software Processing Example> Next, the processing of various devices provided in the MRI system SYS disclosed in this application will be described. In the MRI apparatus 1, the magnetic field generating unit 100 and the electromagnetic wave irradiation unit 101 of the MR main unit mechanism 10 are operated by the control of the MR control mechanism 11 based on the operation of the operator using the operation unit 115, and the MR signal emitted from a subject such as a human body, for example, from the chest, lower abdomen, etc., is detected by the signal detection unit 102. The signal detection unit 102 performs detection multiple times while changing the echo time (TE) from the irradiation of electromagnetic waves such as RF pulses to the detection of the MR signal. Furthermore, the signal detection unit 102 outputs multiple MR signals with different echo times to the MR control mechanism 11. The MR control mechanism 11 outputs the MR signal to the analysis device 2.

[0036] Figure 3 is a flowchart illustrating an example of the analysis process of the analysis device 2 provided in the MRI system SYS disclosed in this application. The analysis device 2, which receives multiple MR signals output from the MRI device 1 through the input unit 22, performs the analysis process. Specifically, the control unit 20 of the analysis device 2 reads the analysis program 210 stored in the storage unit 21 and performs the analysis process by executing various steps included in the analysis program 210.

[0037] The control unit 20 of the analysis device 2 reads one of the one or more comparison criteria stored in the reference storage unit 211 of the storage unit 21 and sets it for comparison (step S1). The criteria set in step S1 are selected automatically or manually based on the operation of the person in charge, depending on the disease or test item that is the subject of the analysis process.

[0038] The control unit 20 acquires multiple MR signals detected at different echo times (step S2), and acquires the phase component from the acquired MR signals (step S3). In the processing example shown in steps S2 to S3, the analysis device 2 acquires the MR signal and then acquires the phase component. Alternatively, the MRI device 1 may output the phase component of the MR signal as a phase image, and the analysis device 2 may acquire it by receiving the input of the phase component of the MR signal.

[0039] The phase component of the MR signal acquired in step S3 will now be explained. Figure 4 is a conceptual diagram illustrating the motion of the MR signal processed by the analysis apparatus 2 disclosed in this application. Hydrogen atoms in the sample undergo precession (rotation) in the magnetic field atmosphere generated by the magnetic field generator 100. Figure 4 conceptually shows the state of precession in the magnetic field atmosphere. Precession in the magnetic field atmosphere can be decomposed into components such as amplitude and phase. The phase change based on the spin of the hydrogen atoms in the state illustrated in Figure 4 can be expressed as equation (1) below.

[0040] Δφ = Δω・Δt = γ・ΔB・tTE ...Equation (1) where Δφ: phase change Δω: angular velocity change γ: gyromagnetic ratio ΔB: local magnetic field change tTE: echo time (TE)

[0041] Figure 5 is a conceptual diagram illustrating the precession of the MR signal processed by the analysis device 2 disclosed in this application. Precession can also be represented as a complex number, as illustrated in Figure 5. In Figure 5, the horizontal axis represents the real number axis, and the vertical axis represents the imaginary number axis. From the MR signal based on precession, indicated by the thick arrows, an amplitude component (amplitude image) shown as equation (2) and a phase component (phase image) shown as equation (3) can be obtained. The phase image contains information related to the angle of rotation of the hydrogen atom and can be imaged regardless of the magnetic field strength.

[0042] M = (Re^2 + Im^2)^(1 / 2) ...Equation (2) tanφ = Im / Re ...Equation (3) φ = tan^-1(Im / Re) where Re: real number Im: imaginary number M: magnitude φ: phase

[0043] Returning to the flowchart of FIG. 3, the control unit 20 corrects the phase component of the MR signal by an unwrapping process (step S4), and further corrects it by a high-frequency component emphasis process (step S5). Since the phase component (phase image) is angle information, it can only be expressed in the range of -π to +π, resulting in aliasing. In step S4, the phase component of the MR signal is corrected by the unwrapping process that unfolds such aliasing. Further, in step S5, high-frequency components are extracted by the high-frequency component emphasis process. As the high-frequency component emphasis process, for example, processes such as high-pass filter processing (low-cut filter processing), band-pass filter processing, and subtract background filter processing are used. The high-pass filter processing is processing by a high-pass filter that passes components equal to or higher than a preset predetermined frequency and attenuates components lower than the predetermined frequency. The band-pass filter processing is processing by a band-pass filter that relatively emphasizes the band components by passing components in a preset frequency band and attenuating components in other frequency bands. The subtract background filter processing is processing using a subtract background filter that estimates the background component in an image and subtracts it from the original image to remove the background. The high-frequency component emphasis process includes all other processes that emphasize predetermined high-frequency components for the purpose of deriving more effective support information that contributes to the determination of the state of the subject, and an optimal process can be selected according to the state of the subject.

[0044] FIG. 6 is a graph showing changes in the phase component of an MR signal processed by the analysis device 2 disclosed in the present application. In FIG. 6, the horizontal axis represents the distance related to angle (the distance between the start point and end point when an arbitrary line is drawn on the image) in units of mm, and the vertical axis represents the phase value (phase angle) as the intensity related to phase in units of rad, showing the relationship therebetween. As exemplified in FIG. 6, the phase value is aliased every 2π distance and exhibits a periodic sawtooth wave behavior.

[0045] Figure 7 is a conceptual diagram illustrating the unwrapping process of the MR signal processed by the analysis device 2 disclosed in this application. Figure 7 conceptually shows the behavior of the MR signal before correction on the left and the behavior of the MR signal after correction by the unwrapping process on the right. As illustrated in Figure 7, the unwrapping process corrects sawtooth wave-like changes by integrating the phase values ​​while retaining values ​​every 2π.

[0046] Figure 8 is a list of examples of images related to MR signals processed by the analysis device 2 disclosed in this application. The upper row of Figure 8 shows an image of an MR signal with an echo time of 21 msec, and the lower row shows an image of an MR signal with an echo time of 48 msec. The images in the upper and lower rows, from left to right, show an amplitude image showing the amplitude component, a phase image showing the phase component, a corrected image by unwrapping processing, and a corrected image with high-pass filtering as high-frequency component enhancement processing. The analysis device 2 disclosed in this application performs unwrapping processing (step S4) on the phase component of the MR signal acquired in step S3 shown in the second column, as shown in the third column, and then performs high-pass filtering processing (step S5) as shown in the fourth column. The image after high-pass filtering is an image with enhanced high-frequency components. In the image after high-pass filtering, the high-frequency components indicated by the arrows are highly likely to be calcified areas and may indicate benign or malignant breast cancer. If calcium oxalate is expressed due to calcification, the area is judged to be highly likely to be benign. Furthermore, if calcium phosphate is present due to calcification, the area is considered highly likely to be malignant breast cancer. Even in cases of such malignant breast cancer, it is estimated that 80% can be cured by detecting the affected area and providing appropriate treatment.

[0047] Returning to the flowchart in Figure 3, the control unit 20 derives the slope of the phase value with respect to the echo time from the corrected phase component (step S6). The inventors of the present invention have found that the slope of the phase value with respect to the echo time differs depending on the component of the calcium salts of calcified sites that manifest as breast cancer. In step S6, the slope is derived with the aim of supporting the identification of the components of the calcified site.

[0048] FIG. 9 is a graph showing an example of the change in phase value with respect to the echo time of MR signals processed by the analysis device 2 of the present application. In the graph illustrated in FIG. 9, the horizontal axis represents echo time in units of msec, and the vertical axis represents phase value in units of rad, showing the measurement results of various calcium salts. As the various calcium salts, calcium oxalate (sampled from urinary calculus), clam (main component is calcium carbonate), calcium phosphate (sampled from urinary calculus), and tooth (main component is calcium phosphate) were used. Calcium phosphate is a calcium salt that appears as malignant breast cancer. The phantoms of calcium oxalate and calcium phosphate are used after the components of samples collected from urinary calculus are identified by component analysis using an infrared absorption spectroscopy method. As illustrated in FIG. 9, various calcium salts exhibit different slopes depending on their main components. It should be noted that although calcium phosphate from urinary calculus and calcium phosphate collected from teeth are in different forms, their main components are the same, and thus they showed substantially the same slope. The inventors of the present application have obtained the finding that for calcium phosphate and calcium oxalate that appear in the body, although the intercepts may differ significantly due to factors such as the physique of the subject, the slope is substantially constant.

[0049] Returning to the flowchart of FIG. 3, the control unit 20 compares the derived slope with a preset reference stored in the storage unit 21 (step S7).

[0050] The pre-set criteria in step S7 are comparison data such as various reference values ​​and reference ranges stored in the reference storage unit 211 of the storage unit 21. For example, a threshold value to be compared with the derived slope (the ratio of the change in phase value to the change in echo time) can be exemplified as a pre-set criterion. The threshold value is set to a value included in 0.04 to 0.05, such as 0.04 or 0.05. If a threshold value is set as a criterion, in step S6, the derived slope is compared with the threshold value. Alternatively, a range of slopes can be set as a criterion. For example, 0.05 to 0.07 can be set as the first range, and 0.03 to 0.04 can be set as the second range. Here, the second range is set as the range to which slopes smaller than the first range belong. Then, it is determined by comparison whether there are parts belonging to the first range or parts belonging to the second range.

[0051] Figure 10 is a graph showing an example of the results of an experimental analysis process using the analysis device 2 of the present invention. Figure 10 shows the results obtained by experimentally performing the analysis process up to step S6 of the present invention, which involves deriving the slope, on two subjects. In this experimental analysis process, where the echo time is set to two points, the example of subject 1 shows a slope of 0.03, which is smaller than the threshold (0.04) and belongs to the second range (0.03 to 0.04). The example of subject 2 shows a slope of 0.06, which is larger than the threshold (0.04) and belongs to the first range (0.05 to 0.07).

[0052] Returning to the flowchart in Figure 3, the control unit 20 derives support information to assist in determining the state of the subject based on the comparison results (step S8). For example, when the chest is the subject, if the slope is greater than the threshold set as the standard in step S7, in step S8, the control unit 20 derives support information to assist in determining that the observed object in the subject is benign calcium oxalate. Also, if the slope is smaller than the threshold, the control unit 20 derives support information to assist in determining that it is malignant calcium phosphate. Furthermore, if the slope falls within the first range set as the standard in step S7, in step S8, the control unit 20 derives support information to assist in determining that the observed object in the subject is benign calcium oxalate. Also, if the slope falls within the second range, the control unit 20 derives support information to assist in determining that it is malignant calcium phosphate.

[0053] The control unit 20 then outputs the derived support information from the output unit 24 (step S9). In step S9, the output from the output unit 24 is performed by methods such as displaying the support information on a monitor or printing it with a printer. The support information is output as text information such as, for example, numerical values, graphs, and images showing the analysis results, along with "Calcification is observed, but it is highly likely to be benign calcium oxalate," or "Calcification is observed, and it may be malignant calcium phosphate. Further examination is required."

[0054] As described above, the analysis device 2 performs the analysis process. The physician then reviews the outputted support information and makes a judgment regarding the subject.

[0055] As detailed above, the analysis device 2 disclosed in this application analyzes the phase component of the MR signal obtained from the subject by the MRI device 1 by deriving the slope of the phase value with respect to the echo time, and comparing the derived slope with a reference. This provides excellent effects, such as supporting the physician's judgment regarding the subject's condition. For example, compared to mammography, which is currently widely used as a chest examination, the analysis device 2 disclosed in this application does not require procedures such as compressing and thinning the breast tissue, so the subject does not feel any pain, thus reducing the psychological barrier to screening and potentially improving the screening rate. Furthermore, it can lead to early detection and early treatment, suppressing the mortality rate from breast cancer and increasing the possibility of complete cure, thus providing excellent effects.

[0056] The analytical method using the analytical device 2 disclosed in this application uses the human body as the subject, and the examination target is not limited to the chest, but can be various parts of the human body such as the lower abdomen. As another example, an analytical method used to support the examination of prostate cancer will be described using the lower abdomen as the examination target. For example, according to the April 29, 2025 issue of Scientific Reports, it has been reported that the scientific characteristics of microcalcification correlate with clinical markers. Prostate calcification is mainly due to hydroxyapatite (HAP) and whitlockite (WH), both of which are types of calcium phosphate. It is known that the zinc concentration in the area surrounding the prostate is 10 to 20 times higher than in other normal tissues throughout the body. It has been reported that the higher the zinc ion concentration, the more unstable the HAP lattice becomes, leading to the formation of whitlockite. Furthermore, as the tumor malignancy grade (Gleason score) of prostate cancer increases, zinc levels decrease, indicating that hydroxyapatite increases with higher malignancy grade. The analytical method disclosed in this application utilizes this scientific characteristic for analysis.

[0057] Figure 11 is a graph showing an example of the change in phase value with respect to echo time of an MR signal processed by the analysis device 2 disclosed in this application. The graph in Figure 11 shows the measurement results of various calcium salts, with echo time in msec units on the horizontal axis and phase value in rad units on the vertical axis. As the various calcium salts, hydroxyapatite and β-tricalcium phosphate, which is structurally similar to wittrockite as a model substance, were used. As illustrated in Figure 11, it was shown that the slope differs if the molecular formula (structural formula) is different. Also, as illustrated in Figure 11, the relationship between echo time and phase value can be approximated by the linear equation "y = 0.037x - 0.008" from the measurement results of hydroxyapatite, and can be approximated by the linear equation "y = 0.026x - 0.025" for β-tricalcium phosphate.Therefore, when the analysis method disclosed in this application is used for prostate cancer examination with the lower abdomen as the subject, it is possible to support the examination by setting the slope standard to 0.03, for example.

[0058] The analytical apparatus 2, etc., disclosed herein is not limited to the embodiments described above, but can be implemented in various other forms. Therefore, the embodiments described above are merely illustrative in all respects and should not be interpreted restrictively. The technical scope of the present invention is described by the claims and is not restricted in any way by the text of the specification. Furthermore, all modifications and changes falling within the equivalent scope of the claims are within the scope of the present invention.

[0059] For example, in the above embodiment, the chest of a human body was used as the subject and the method was applied to the analysis of breast cancer. However, the analysis device 2 disclosed in this application can be applied to the analysis of various conditions that express calcium salts. For example, the analysis device 2 disclosed in this application can be applied to the analysis of conditions that express calcium salts, such as ureteral stones, kidney stones, prostate stones, and thyroid calcification. Furthermore, by accumulating various data, it is expected that the method can be applied to analyses other than those of calcium salts. For example, it is expected to be applicable to iron deposition in iron metabolism disorders and neurodegenerative diseases (Parkinson's disease, Alzheimer's disease, multiple system atrophy, etc.), and Wilson's disease in which copper is deposited in the basal ganglia and liver.

[0060] SYS MRI System 1 MRI Device 10 MR Main Unit Mechanism 100 Magnetic Field Generator 101 Electromagnetic Wave Irradiation Unit 102 Signal Detection Unit 11 MR Control Mechanism 110 Control Unit 111 Drive Unit 112 Output Control Unit 113 Signal Input Unit 114 Signal Output Unit 115 Operation Unit 2 Analysis Device 20 Control Unit 21 Memory Unit 210 Analysis Program 211 Reference Memory Unit 22 Input Unit 23 Operation Unit 24 Output Unit

Claims

1. An analysis device for analyzing MR (Magnetic Resonance) signals obtained from a subject using an MRI (Magnetic Resonance Imaging) device, comprising: a reference storage unit that stores one or more references for comparison; a reference setting means that reads one reference from the reference storage unit and sets it for comparison; a phase acquisition means that acquires the phase component of the MR signal; a correction means that corrects the acquired phase component by unwrapping processing; a slope derivation means that derives the slope of the phase value with respect to the echo time from the corrected phase component; a comparison means that compares the derived slope with the set reference; and a support information derivation means that derives support information to assist in determining the state of the subject based on the comparison result.

2. The analysis apparatus according to claim 1, characterized in that the correction means performs high-frequency component enhancement processing on the unwrapping phase component.

3. The analysis apparatus according to claim 1 or 2, wherein the subject is a human body, and the support information derivation means derives support information that assists in determining whether the object of observation within the subject is benign or malignant, as a determination of the state of the subject based on the results of comparing the inclinations.

4. The analysis apparatus according to claim 1 or 2, wherein the subject is a human body, and the support information derivation means derives support information that assists in determining whether the object of observation within the subject is calcium phosphate or calcium oxalate, as a determination of the state of the subject based on the results of comparing the inclinations.

5. The analytical apparatus according to claim 1 or 2, wherein the subject is a human body, and the support information derivation means derives support information that assists in determining whether the object of observation within the subject is hydroxyapatite or wittrockite, as a determination of the state of the subject based on the results of comparing the inclinations.

6. An MRI system comprising: an MRI apparatus that applies a magnetic field and irradiates electromagnetic waves to a subject and acquires an MR signal; and an analysis apparatus according to any one of claims 1 to 5 that analyzes the MR signal received by the MRI apparatus.

7. An analysis method using an MRI (Magnetic Resonance Imaging) device and an analysis device for analyzing MR (Magnetic Resonance) signals obtained from a subject by the MRI device, characterized by performing the following steps: a reference setting step of reading one reference from a reference storage unit that stores one or more references for comparison and setting it for comparison; a phase acquisition step of acquiring the phase component of the MR signal; a correction step of correcting the acquired phase component by unwrapping; a slope derivation step of deriving the slope of the phase value with respect to the echo time from the corrected phase component; a comparison step of comparing the derived slope with the set reference; and a support information derivation step of deriving support information to assist in determining the state of the subject based on the comparison result.

8. An analysis program that causes a computer to analyze an MR (Magnetic Resonance) signal obtained from a subject by an MRI (Magnetic Resonance Imaging) device, characterized in that the computer is caused to execute: a reference setting step of reading one reference from a reference storage unit that stores one or more references for comparison and setting it for comparison; a phase acquisition step of acquiring the phase component of the MR signal; a correction step of correcting the acquired phase component by unwrapping processing; a slope derivation step of deriving the slope of the phase value with respect to the echo time from the corrected phase component; a comparison step of comparing the derived slope with the set reference; and a support information derivation step of deriving support information to assist in determining the state of the subject based on the comparison result.